Mergers & Acquisitions Mergers & Acquisitions

J&J-TachoSil deal headed for in-depth EU investigation

By Natalie McNelis
  • 25 Mar 2020 05:02
  • 25 Mar 2020 05:09

Johnson & Johnson’s purchase of the TachoSil surgical-patch business from Japan's Takeda Pharmaceutical is headed for an in-depth EU investigation, MLex has learned.

That would put the European Commission’s deadline to decide on the deal in August.

TachoSil is a surgical patch used to control bleeding in cardiovascular and liver

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Natalie McNelis

Senior Correspondent

Natalie McNelis covers mergers for MLex in Brussels. Before joining MLex in 2017, she spent 20 years as an international trade and competition lawyer in law firms including Stibbe and WilmerHale. Natalie has a BA in English from Mount Holyoke College, a JD from Harvard Law School and an LLM in EU law from KU Leuven. She is admitted to the bar in New York.

Discover MLex

Stay on top of global regulatory developments

Latest News